Pierre A.
- Country
- France
- Department
- ICU
Research Overview
- Safety, Dose-Finding, and Pharmacodynamic Study of BAY 3389934 in Patients with Sepsis-Associated Coagulopathy
- Phase IIb Randomized, Placebo‑Controlled Multicenter Trial of Intravenous Sivelestat for Restoring Fibrinolysis in Septic Coagulopathy
- BETARGET: Randomized Trial of Individualized Beta‑lactam Dosing (TDM, MIC‑guided, Model‑Based) vs Standard Care in ICU Patients with Sepsis due to Gram‑negative Bacilli
Data & Insights
Has run more than one trial at 51 of 224 partner sites.
Specializations
Critical Cardiac Care
The investigator specializes in treating patients with post-resuscitation syndrome and out-of-hospital cardiac arrest conditions. Their research encompasses cardiac emergency interventions and recovery protocols, with particular attention to patients experiencing hemodynamic failure and shockable rhythm complications.
- Post-cardiac arrest management
- Hemodynamic stabilization
- Cardiac arrhythmia treatment
Infectious Disease Management
Focus areas include the treatment of severe community-acquired bacterial pneumonia and viral lung infections. The investigator studies innovative therapeutic approaches for patients requiring supplemental oxygen and those with severe respiratory complications.
- Bacterial pneumonia interventions
- Viral respiratory care
- Oxygen therapy management
Critical Care Complications
The investigator addresses complex critical care conditions including sepsis-induced hypotension, sepsis-associated acute kidney injury, and coagulopathy. Their work extends to managing immune system complications in intensive care settings.
- Sepsis management
- Renal function preservation
- Immunotherapy applications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.